Prostate Cancer


The NINJA clinical trial aims to compare two emerging schedules of radiotherapy in the treatment of prostate cancer.

Trial overview


Prostate cancer


Novel Integration of New prostate radiation therapy schedules with adjuvant Androgen deprivation.

Eligibility criteria

To be considered for the study you must meet the following criteria:

  • Unfavourable intermediate risk prostate cancer
  • OR low-high risk prostate cancer
  • No metastatic disease
  • Planned to receive 6  months for androgen deprivation therapy

Study details

This trial is looking at comparing two different radiotherapy treatment schedules called stereotactic body radiotherapy (abbreviated as SBRT) in patients with prostate cancer. The aim is to develop better methods of treatment for prostate cancer using this type of treatment, and further understand what causes some of the side effects of treatments.

Further information

For more information regarding this clinical trial click here.

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.